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The acidic 80 kDa protein kinase C (PKC) substrate was purified from 2.3 x lw” Swiss 3T3 fibroblasts. Partial amino acid sequence data were 
obtained from five peptides generated by S. aureas V8 cleavage of the protein, enabling a total of 91 amino acid residues to be assigned. The se- 
quences of these five peptides were compared to the deduced amino acid sequences of acidic SO-87 kDa PKC substrates from both actively pro- 
liferating A43 1 epidermal carcinoma cells, and fully differentiated neural tissue. Despite their similar physical properties, there was no homology 
between the peptides derived from the fibroblast 80 kDa protein and the PKC substrate from A431 cells. However, there was 66% homology with 
the 87 kDa bovine brain protein within the regions covered by the peptides (about 30% of the total protein). Furthermore, comparison of the 
peptides from the fibroblast 80 kDa protein with proteolytic peptides derived from the acidic 80 kDa rat brain protein revealed an overall homology 
of 89%. These data provide the first direct evidence that the 80 kDa PKC substrate from Swiss 3T3 fibroblasts is closely related to the 80-87 kDa 
PKC substrates detected in fully differentiated neural tissue. 
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1. INTRODUCTION 
The non-tumorigenic murine Swiss 3T3 fibroblast 
has proved to be an extremely useful model system for 
identifying both extracellular factors that modulate cell 
growth and for elucidating the early signals that lead to 
mitogenesis. One of the major signal transduction 
pathways activated by a variety of extracellular stimuli 
involves the enzyme protein kinase C (PKC) [l]. Since 
the mechanism(s) through which PKC-mediated signals 
elicit mitogenesis remains largely unknown, it is impor- 
tant to characterize the physiological substrates of this 
kinase. 
dephosphorylation of this protein [17]. These findings 
raise the possibility that the 80 kDa protein is involved 
in PKC-mediated mitogenic signal transduction. 
An acidic protein that migrates with an apparent 
molecular mass of 80 kDa in SDS polyacrylamide gels 
has been identified as a major and specific substrate for 
PKC in quiescent mouse 3T3 fibroblasts [2-61. The 
phosphorylation of this protein is stimulated by phor- 
bol esters [2,4,7], diacylglycerols [7-91, platelet derived 
growth factor [2,7,10], fibroblast growth factor 
[3,7,11], bombesin [6,10,12], vasopressin [13,14], 
bradykinin [ 151 and Pasteurella multocida toxin [16], 
all of which stimulate DNA synthesis in quiescent Swiss 
3T3 cells [l]. In addition, removal of either phorbol 
esters or mitogenic peptides results in rapid 
Acidic 80-87 kDa PKC substrates have also been 
identified in the brain of several species [18,19,21,22]. 
In rodents, the protein migrates slightly faster by SDS- 
PAGE, is more acidic and shows different im- 
munological cross-reactivity than in other species 
[ 18,191. Chromatographic heterogeneity has also been 
reported within the same species [20,21]. Recently, the 
isolation of a cDNA encoding the 87 kDa PKC 
substrate from bovine brain was reported [23]. The 
purification and sequencing of proteolytic peptides of 
the rat brain 80 kDa PKC substrate enabled a com- 
parison to be made of the rat and bovine proteins. This 
revealed an overall homology of 54% for the regions 
covered by the peptides [24]. Hence, these acidic PKC 
substrates are similar but not identical. 
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Acidic 65-87 kDa PKC substrates that appear to be 
related to the Swiss 3T3 fibroblast 80 kDa protein have 
also been detected in a variety of mammalian cells in 
culture [2,4,7,18,22,25,26]. However, no direct 
evidence is yet available to suggest hat these proteins 
are related to each other or to the neuronal 80-87 kDa 
PKC substrates. Indeed, there has been a recent report 
on the cloning and sequencing of an acidic 80 kDa PKC 
substrate from the human epidermal carcinoma cell line 
A431 [27]. Comparison of the deduced amino acid se- 
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quence of this protein with peptides generated from the 
rat brain 80 kDa PKC substrate [24] or the deduced 
amino acid sequence of the 87 kDa bovine brain pro- 
tein 1231, indicates that the protein from A431 cells is 
unrelated to the acidic 80-87 kDa PKC substrates 
isolated from brain. Consequently, it was important to 
determine whether the 80 kDa protein detected in non- 
excitable Swiss 3T3 fibroblasts, which are a model cell 
line for elucidating mitogenic signalling pathways, ex- 
presses an 80 kDa PKC substrate related to any of 
those identified in brain or cultured epidermal car- 
cinoma cells. 
In the present study, we report the purification and 
partial amino acid sequence of the acidic 80 kDa PKC 
substrate from Swiss 3T3 fibroblasts. These results pro- 
vide direct evidence that this protein is related to the 
acidic 80-87 kDa PKC substrate proteins isolated from 
neural tissue, but not from epidermal carcinoma cells. 
2. MATERIALS AND METHODS 
2.1. Materials 
Sephadex G-150 (fine), phenylsepharose and liquid 
chromatography columns were purchased from Pharmacia 
Biotechnology; [Y-~~P]ATP (3.0 Ci/mmol) was from Amersham In- 
ternational UK; DEAE-cellulose was from Whatman; phorbol 
dibutyrate (PDBu), histone 111s and phosphatidylserine (PS) were 
from Sigma (St Louis, MO); protein assay reagent was from Pierce, 
Aquacide II from Calbiochem and silver staining kits were from 
Koch-Light Ltd. 
Protein kinase C was partially purified from rat brain by the 
method of Walsh et al. [28] and assayed using the phosphocellulose 
spot technique [29] as described [13]. 
2.2. Methods 
2.2.1. Assay of the 80 kDa protein 
The 80 kDa protein was assayed by phosphorylation. Protein 
samples from chromatographic fractions were incubated with 50 mM 
Tris/HCl, pH 7.5, 10 mM MgC12, 500 ng/ml phorbol dibutyrate, 
500 pM CaCl2, 100 pg/ml phosphatidylserine, 50 pM [Y-~~P]ATP 
(5 x lo5 cpm/nmol) and 5 ,ul PKC (spec. act. 22 nmol “P/mg/min) 
in a final volume of 100 pl. After incubation for 30 min at 37’C, the 
reaction was terminated by the addition of 20 ~1 five-times concen- 
trated SDS-sample buffer (50% glycerol, 12.5% SDS, 50 mM 
Tris/HCl pH 8.0, 10 mM EDTA, 12.5% 2-mercaptoethanol). 
Samples were boiled for 5 min, and then subjected to SDS-PAGE. 
The bands corresponding to the 80 kDa protein on autoradiographs 
of dried gels were excised and quantitated by Cerenkov counting US- 
ing a liquid scintillation counter (Beckman Instruments). 
2.2.2. Cell culture 
Cultures of Swiss 3T3 cells [30] were maintained in 90 mm Nunc 
Petri dishes in Dulbecco’s modified Eagle’s medium containing 10% 
fetal bovine serum, penicillin (100 units/ml) and streptomycin 
(100 pg/ml) in humidified air/C02 (9: 1) at 37°C. For the prepara- 
tion of the cytosolic fraction, 3 x lo6 cells were subcultured into 
1850 cm2 Falcon roller bottles and were grown to confluence without 
a change of medium for 6-7 days. The final density was 3-5 x 10’ 
cells/flask. 
2.2.3. Preparation of the cytosolic fraction 
600 roller bottles, containing 2.3 x 10” cells, were washed twice 
with 150 ml phosphate-buffered saline (PBS; 0.14 M NaCl, 5 mM 
KCl, 10 mM Na2HP04, 1.8 mM KH2P04, pH 7.2) at room 
temperature. All subsequent steps were carried out at 4°C. The cells 
were harvested by gentle scraping into PBS containing 5 mM MgCl2, 
1 mM EGTA, 1 mg/ml bacitracin, 10 pg/ml aprotinin, 1 mg/ml soy- 
bean trypsin inhibitor and 50 ,uM phenylmethanylsulphonyl fluoride. 
The cells were then pelleted by centrifugation at 750 x g for 10 min 
and resuspended at 5 x IO6 cells/ml in 50 mM Hepes pH 7.4, 5 mM 
MgCl2, 1 mM EGTA and the above protease inhibitors. Cells were 
then disrupted using a dounce homogenizer (A pestle, 75 strokes). 
The homogenate was centrifuged at 500 x g for 10 min to remove 
nuclear material and intact cells, and the supernatant was centrifuged 
again at 30000 x g for 30 min. The resulting supernatant, containing 
the 80 kDa protein was collected. 
2.2.4. Purification of the 80 kDa protein from Swiss 3T3 fibroblasts 
The supernatant fractions (2.60 liters) were heated at 100°C in 
200 ml aliquots for 3 min. Heat-labile proteins were pelleted by cen- 
trifugation at 30000 x g for 30 min. The supernatant, containing the 
80 kDa protein was collected. All subsequent steps were carried out 
at 4°C. 2.56 liters of the heat-stable extract were incubated with 
600 ml of settled DEAE-cellulose previously equilibrated with 
20 mM Tris-HCl, pH 7.5, 1 mM EDTA (TE buffer), with occasional 
stirring for 1 h. After washing with 2 liters of the TE buffer, the 
slurry was poured into a column (5 cm x 30 cm), and bound proteins 
were eluted with a 2 liter linear gradient of 0 to 1.0 M NaCl in TE 
buffer at 1.25 ml/min. 15 ml fractions were collected. The 80 kDa 
protein eluted between 135 and 265 mM NaCl. Active fractions were 
pooled and dialysed against 3 changes of 4 liters TE buffer. The 
dialysate was then applied to four DEAE-cellulose minicolumns 
(2 ml) equilibrated in TE buffer. The 80 kDa protein was eluted with 
10 x 1 ml aliquots of 2 M NaCl, 20 mM HCI. Active fractions were 
pooled and concentrated to 8.0 ml with Aquacide II. The concen- 
trated sample containing the 80 kDa protein was applied to a 
Sephadex G-150 gel-filtration column (82 cm x 2.5 cm) equilibrated 
with 1 M NaCl, 20 mM HCl. The 80 kDa protein eluted between 200 
and 230 ml. Active fractions were pooled and dialyzed against 3 
changes of 4 liter TE buffer before concentration to 1.9 ml with 
Aquacide II. The 80 kDa protein was phosphorylated with PKC and 
then electrophoresed on a 1.5 mm thick 7.5% SDS-polyacrylamide 
gel. After electrophoresis, protein was visualized by brief staining 
with Coomassie blue (0.1070). The band corresponding to the 80 kDa 
Table I 
The purification of the 80 kDa protein from Swiss 3T3 fibroblasts 
Stage 
Cytosolic fraction 
Boiled extract 
DEAE-cellulose 
G- 150 gel filtration 
Electra-elution 
Volume Total Total Specific Fold Yield 
(ml) protein activity activity purification (o/o) 
(mg) (lo4 cpm) (l@ cpm/mg) 
2600 936 402 0.43 1.0 100 
2560 163.8 221 1.35 3.1 54.9 
581 28.2 124 4.4 10.2 30.8 
31.5 0.267 17.7 66 153.5 4.4 
0.25 0.0098 15.7 1604 3730 3.9 
All procedures described in section 2 
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protein was excised and electroeluted from the gel slice as previously 
described [24]. A summary of the purification of the 80 kDa protein 
from 2.3 x 10” Swiss 3T3 fibroblasts is shown in Table I. 
2.2.5. Proteolytic cleavage of the 80 kDa protein and peptide 
separation 
The purified 80 kDa protein (10 ,ug) was digested with S. ~~reus V8 
protease at 25°C for 24 h, with an enzyme/substrate ratio of 1: 30. 
The resulting peptides were resolved on a reverse-phase HPLC system 
(Waters), using a Brownlee Aquapore RP-300 column (2.1 x 
100 mm). The following buffer system was used: Buffer A (0.08~0 
trifluoroacetic acid in acetonitrjle/water 1:99 v/v); Buffer B (0.~~0 
tri~uoroacetic acid in acetonitrile/water 90: 10 v/v). The column was 
equilibrated in Buffer A and developed at a flow rate of 0.4 mllmin 
with a gradient of O-30% Buffer B in 35 min, 30-45% Buffer B in 
70 min followed by 4%100% Buffer B in 90 min. Peptides were 
detected by monitoring absorbance at 220 nm. 
2.2.6. Peptide sequence analysis 
HPLC-purified peptides generated from the S. aureus V8 digest of 
the 80 kDa protein were subjected to gas/liquid phase microsequenc- 
ing on an Applied Biosystems model 47714 peptide sequencer, equip- 
ped with a miniaturised reaction cartridge and utilising rapid cycle 
chemistry and on-line analysis programs (Totty and Mattaliano, sub- 
mitted for publication). 
3. RESULTS AND DISCUSSION 
To determine whether the acidic 80 kDa protein of 
Swiss 3T3 fibroblasts is related to any of the 
go-87 kDa PKC substrates from brain [l&21] or 
cultured epidermal carcinoma cells [27], we have under- 
taken to characterize the fibroblast protein by purifica- 
tion, proteolysis and subsequent amino acid sequencing 
of the peptide fragments. 
Previous studies have shown that the 80 kDa PKC 
substrate from Swiss 3T3 fibroblasts is heat stable 
[ 18,191, Therefore, a purification scheme involving 
heat treatment, DEAE-cellulose chromatography, 
G-l 50 gel filtration and electroelution from preparative 
SDS polyacrylamide gels was followed as previously 
described for the purification of the rat brain protein 
[19,24]. Approximately 10 lug of homogeneous 80 kDa 
protein was isolated from the cytosolic fraction of 
2.3 x 10” confluent, quiescent Swiss 3T3 fibroblasts 
(Table I). 
The N-terminus of the 80 kDa PKC substrate from 
Swiss 3T3 fibroblasts has been reported to be blocked 
by myristoylation 1251. Therefore, to obtain amino acid 
sequence information, purified samples of the 80 kDa 
protein were digested with S. uureus V8 protease and 
the resulting peptides separated by reverse-phase 
HPLC (Fig. 1). Selected peaks were applied to a gasfli- 
quid phase sequencer, and amino acid sequence obtain- 
ed at the 30-100 pmol level. A total of 9 peaks yielded 
homogeneous peptides. The amino acid sequences of 
these peptides are presented in Fig. 1. In all, 91 amino 
acid residues were assigned from the analysis. Peptides 
Ci and Ei are extended versions of peptides C and E 
respectively, and were presumably generated through 
incomplete proteolytic cleavage of the protein by S. 
areus V8 protease. 
0 5 30 35 40 45 
RETENTION TIME, MIN 
Fig. 1. Purification of S. aureus VS proteolytic peptides from the 
Swiss 3T3 80 kDa protein by reverse phase HPLC. 10 gg of 80 kDa 
protein purified from preparative polyacrylamide gels was digested 
with S. aureus V8 protease and separated by HPLC as described in 
section 2. Amino acid sequence information was obtained from 
peptides labelled A-Et, and is shown in single amino acid code above 
each peak. X indicates that no residue could be defined. Residues that 
could not be unequivocally identified are enclosed in parentheses. 
Sequences of peptide B were observed in two peaks of the digest. In 
both cases, the signal of the PTH-derivative dropped sharply in the 
12th cycle of sequencing, and after this cycle, no further PTH- 
derivatives were detected. Therefore, it is likely that peptide B was 
sequenced to the end. Sequences of peptide C were observed in four 
separate peaks. Similarly, sequences of peptide E were detected in ‘ 
three separate peaks of the digest. Peptides Cr and Et are extended 
versions of peptides C and E respectively, and are likely to originate 
from partial proteolytic cleavage by S. aureus V8 protease. 
The sequence data we have obtained of the 80 kDa 
protein from Swiss 3T3 cells provide an excellent op- 
portunity to define the relationship between the 
fibroblasti~ protein and other acidic PKC substrates. A 
comparison of the partial amino acid sequence of the 
fibroblast 80 kDa protein with the predicted amino 
acid sequence of the acidic 80 kDa protein from the 
human epidermal carcinoma cell line A431 [27] reveal- 
ed no regions of homology, despite their similar ap- 
parent molecular weight on SDS-PAGE, ability to be 
phosphorylated by PKC, heat stability and acidic ~1. In 
addition, no significant homology was found between 
the fibroblast 80 kDa protein and the PKC substrates 
GAP-43 [3 l] and P47 1321. 
In contrast, a striking relationship was observed bet- 
ween the 3T3 80 kDa protein and acidic PKC substrates 
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B BOY 324 CSPEAPPAEME 82 
lllllll II 
3T3 XSPEAPPAPTAE 
llllllll II RAT XSPEAPPAPYAE 91 
Cl BO” 202 MAMG-EAGAAPGEPTAAPGEE E E GA 58 
3T3 ’ I I I ’ I ~GA.L!&QAGGALL!E 
m IIIIIIIII/IIIIIIl 
RAT MIVUGGOMMPGEOA~AGAAEG(G)E(SR) 92 
D BOV 179 EGGEAEGAAGASAEGGK DEASGGAAA 47 
llIIIlII I 
3T3 GATASGAK DEGAGAGGE 
RAT EAGEGAEAEd&d& 80 
El 
BO” 59 LOMGSAPAAD K EEPAAAGS GA 91 
IIIIIIIIIII I Illll II I 
3T3 LOANGSAPAAD K EEPAAGGS AA 
III lllllll I III/ II I 
RAT LPAXGSAPAAD(K)EEPASGGX(A)TP 94 
Fig. 2. The amino acid sequences of peptides A-E1 of the Swiss 3T3 
fibroblast 80 kDa protein were aligned with the deduced amino acid 
sequence of the bovine brain 87 kDa PKC substrate [23] and with 
proteolpic peptides from the rat brain 80 kDa PKC substrate [24] 
(unpublished data). Vertical lines between amino acids denote 
identical residues. The numbers to the left of the bovine brain 
peptides indicate the position of the sequence within the entire 
protein. The numbers to the right of the bovine and rat brain 
sequences represent he % homology between these peptides and 
those of the fibroblast protein. A gap after amino acid 207 of the 
bovine brain protein was introduced to allow optimum alignment. 
identified in brain tissue. Fig. 2 shows the experimen- 
tally determined peptide seqeunces of the fibroblast 
and rat brain PKC substrates aligned with the predicted 
sequence of the bovine brain protein. Within the 
regions covered by the fibroblast peptides, which repre- 
sent 30% of the bovine brain 87 kDa protein, there was 
66% homology between the two PKC substrates. The 
overall homology between the peptides of the rat brain 
and fibroblast 80 kDa proteins was 89%. Furthermore, 
all of the non-matching residues of the mouse 
fibroblast and rat brain peptides are replaced by con- 
servative substitutions, and are therefore unlikely to 
have a profound effect on the tertiary structure of the 
protein. Analysis of the homology between individual 
peptides identified certain regions within these proteins 
that display a high degree of conservation between 
species (Fig. 2). Peptides B and E, which can be aligned 
with regions at the N-terminus and extreme C-terminus 
of the bovine brain protein, respectively, are highly 
conserved in both bovine and rodent species. This may 
suggest that these domains have functional 
significance. Regions .of greatest divergence can be 
identified in the central portion of the protein, where 
294 
the mouse fibroblast peptides A, C and D show only 
53, 58 and 47% homology with the bovine brain pro- 
tein, respectively. 
In conclusion, the data presented here provide the 
first direct evidence that the acidic 80 kDa protein iden- 
tified as a major substrate of PKC in Swiss 3T3 
fibroblasts is closely related, but not identical to the 
80-87 kDa PKC substrates isolated from the brain of 
several species. Recently, the bovine brain 87 kDa PKC 
substrate was reported to be a calmodulin-binding pro- 
tein in vitro. The affinity for calmodulin was shown to 
be decreased by PKC-mediated phosphorylation of the 
protein [33]. Thus, in neurones, this PKC substrate 
may regulate ionic conductance through alterations in 
free Ca2+. In non-excitable cells, similar molecular in- 
teractions could play a role in Ca2+ signalling of long- 
term responses such as gene expression and cellular 
proliferation, a proposition that warrants further ex- 
perimental work. 
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